Frecuencia de Portadores de Candida Sp en Cavidad Oral de Pacientes Diabéticos de Medellín.

Jessica Bedoya; Elizabeth Correa; Clara María Duque Restrepo; Orville Hernández; Juliana Rendón

doi:10.22490/24629448.515

Vol. 10 No. 17 (2012)

Published

2012-06-15

PDF (Spanish)

How to Cite

Bedoya, J., Correa, E., Duque Restrepo, C. M., Hernández, O., & Rendón, J. (2012). Frequency of Candida sp in the oral cavity of diabetics patients of Medellín. NOVA Biomedical Sciences Journal, 10(17), 33-37. https://doi.org/10.22490/24629448.515

Download Citation

Metrics

Metrics Loading ...

Frequency of Candida sp in the oral cavity of diabetics patients of Medellín.

DOI: https://doi.org/10.22490/24629448.515

Section

Research Article (before OJS)

Jessica Bedoya Universitaria Colegio Mayor de Antioquia

Elizabeth Correa Universitaria Colegio Mayor de Antioquia

Clara María Duque Restrepo Universitaria Colegio Mayor de Antioquia.

Orville Hernández Universitaria Colegio Mayor de Antioquia.

Juliana Rendón Universitaria Colegio Mayor de Antioquia.

Objective: To determine the frequency of Candida species isolates from oral cavities of diabetic patients and to evaluate sensitivity to antimycotic drugs. Material and Methods: Oral cavity samples were collected from patients included in this study after accepting the informed consent. The samples were cultured in Sabouraud Dextrose Agar and in Chromogenic Candida Agar. Api 20 C AUX and growth at 45º C in Sabouraud Dextrose Agar were used to identify Candidaspecies and ATB fungus test was used to evaluate the sensitivity to Fluconazole, Voriconazole and Itraconazole. Results: 200 samples were obtained from the oral cavity of diabetic patients. 96 Candida isolates were obtained: C. albicans (95.4%), C. guillermondii (2.3%)and C. parapsilosis (2.3%). Antimycotic assays revealed the following sensitivity: 97% against Fluconazol 97% and 93% against Voriconazol andItraconazol.Conclusions: C.albicanswas the most isolated species in diabetic patients. Taking into account that these patients are susceptible to acquire infections to different Candida species, it is important to identify which is the infecting species and determine its sensitivity profile.

Candida sp, Diabetics, oral cavity.

Martín Muñoz M. C., Gómez de la Cámara A., Román Martínez A., Ferrando Vivas P., Albarrán Juan M. E., Hawkins F.. Riesgo de infecciones y control metabólico en pacientes con diabetes mellitus tipo

An. Med. Interna (Madrid) [revista en la Internet]. 2004 Mar [citado 2012 Jun 16] ; 21(3): 22-26. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-71992004000300004&lng=es.http://dx.doi.org/10.4321/S0212-71992004000300004

González M, Linares C, Rodríguez E. Prevalencia de trastornos bucales en población con diabetes mellitus tipo 2. RevMedInstMex Seguro Soc 2008; 46 (3): 237-545 [revista en la Internet]. [citado 2012 Jun 16]http://edumed.imss.gob.mx/edumed/rev_med/pdf/gra_art/A127.pdf

Appleton SS. Candidiasis: pathogenesis, clinical characteristics and treatment. J Calif Dent Assoc 2000; 28: 942-948.

García P, Domínguez I, Marín P, García L, Mira J, Candidiasis vulvovaginal resistente a azoles. Enfermedades infecciosas Microbiología clínica. Agosto 2000, Volumen 18, Numero7; 367-368.

Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell RM, Lamey PJ. Oral candidal carriage and infection in insulin-treated diabetic patients. DiabetMed 1999;16(8):675-9.

Duque C, Uribe O, Soto F y Alarcón J. Candidiasis vulvovaginal en Grupo Mujeres gestantes de Medellín. Infect. [en línea].2009, vol.13, n.1, pp 14-20. ISSN 0123-9392.

Zuluaga A, de Bedout C, Agudelo C, et al. Sensibilidad a fluconazol y voriconazol de especies de Candida aisladas de pacientes provenientes de unidades de cuidados intensivos en Medellín, Colombia (2001–2007). RevIberoamMicol. 2010;27(3):125–129

Urizar, Aguirre José Manuel. Candidiasis orales. Revista Iberoamericana de Micología. 2002 ;Vol. 19, pp. 17-21.

Jaimes AA, Hernández PF, Martínez, HE, Rodríguez CAA, Arenas GR. Portadores de Candida en la mucosa oral: tipificación de 35 cepas con CHROMagarCandida. MedIntMex 2008;24(4):262-6.

Ortega, Rodríguez Judy. Candidiasis de la mucosa bucal. Revisión bibliográfica. Revista Cubana de Estomatología. 2002: Vol. 39. Ciudad de La Habana.

Del Toro R, Aldrete MG, Cruz A, Ramírez VM, et al. Manifestaciones orales en pacientes diabéticos tipo 2 y no diabéticos. Invest Salud 2004;3:165-169.

Download Citation

Published

How to Cite

Frequency of Candida sp in the oral cavity of diabetics patients of Medellín.

Declaración de privacidad.

Keywords